Cardiovascular disease is the leading cause of death worldwide. Arterial stenting as a transluminal angioplasty procedure allows re-opening of narrowed vessels and restoring normal blood flow with stent placement. The development of stents ed at the end of 19 century with bare-metal stents (BMS). Now, it has been based on the application of biodegradable or natural decomposed and coated stents. The coated stent has been found to improve BMS properties in terms of biocompatibility, cytotoxicity, and better mechanical and biophysical properties. Also, a biodegradable stent may support the blood micro-vessel during the estimated period of time before downgraded constituents. The biodegradable stent also allows a reinsertion for several months to improve the vessel wall's quality. This paper describes the possible materials for stents and their properties such as design criteria, degradation behavior, disadvantages, and advantages with clinical and preclinical trials to date. Stent degradation allows reinsertion of the stent after several months and improves the vessel wall quality. This paper focuses on developing materials for stents, which describe the possible materials for stents and their properties. Furthermore, the current clinical trial of the new proposed stent will also be highlighted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.